Schedule 13D ownership disclosure
Stoke Therapeutics Inc
Security class unavailable · CUSIP: 86150R107
Event date: 2020-11-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 47.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-20-039684
- Form type
- SC 13D
- Filer
- ATP Life Science Ventures, L.P.
- CIK
- CIK 1593440
- Filed
- Nov 27, 2020
- Reporting period
- Nov 20, 2020
- Description
- Schedule 13D beneficial ownership